115 related articles for article (PubMed ID: 20146949)
1. [Pulmonary arterial hypertension in the elderly subject].
Frachon I; Barnier A; Jobic Y; Gut-Gobert C; Etienne Y; Crutu A; Mialon P; Pasquier E; Nowak E; Mejri M; Couturaud F; Leroyer C;
Rev Mal Respir; 2010; 27(1):30-6. PubMed ID: 20146949
[TBL] [Abstract][Full Text] [Related]
2. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
[TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
[TBL] [Abstract][Full Text] [Related]
4. [Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: diagnostic approach of a single center].
Kayikçioğlu M; Kültürsay H
Anadolu Kardiyol Derg; 2008 Aug; 8(4):279-85. PubMed ID: 18676304
[TBL] [Abstract][Full Text] [Related]
5. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
[TBL] [Abstract][Full Text] [Related]
6. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
[TBL] [Abstract][Full Text] [Related]
7. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N
J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
[TBL] [Abstract][Full Text] [Related]
9. Comparison of baseline predictors of prognosis in pulmonary arterial hypertension in patients surviving ≤2 years and those surviving ≥5 years after baseline right-sided cardiac catheterization.
Batal O; Khatib OF; Dweik RA; Hammel JP; McCarthy K; Minai OA
Am J Cardiol; 2012 May; 109(10):1514-20. PubMed ID: 22360818
[TBL] [Abstract][Full Text] [Related]
10. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Reesink HJ; van der Plas MN; Verhey NE; van Steenwijk RP; Kloek JJ; Bresser P
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):510-6. PubMed ID: 17258590
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis.
Phung S; Strange G; Chung LP; Leong J; Dalton B; Roddy J; Deague J; Playford D; Musk M; Gabbay E
Intern Med J; 2009 Oct; 39(10):682-91. PubMed ID: 19220532
[TBL] [Abstract][Full Text] [Related]
12. Comparison of patients with pulmonary arterial hypertension with versus without right-sided mechanical alternans.
Ito M; Kodama M; Kashimura T; Obata H; Mitsuma W; Hirono S; Tomita M; Ohno Y; Tanabe N; Aizawa Y
Am J Cardiol; 2012 Feb; 109(3):428-31. PubMed ID: 22071213
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
Chapman TH; Wilde M; Sheth A; Madden BP
Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L
Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960
[TBL] [Abstract][Full Text] [Related]
15. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database.
Khush KK; Tasissa G; Butler J; McGlothlin D; De Marco T;
Am Heart J; 2009 Jun; 157(6):1026-34. PubMed ID: 19464413
[TBL] [Abstract][Full Text] [Related]
16. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus.
Prabu A; Patel K; Yee CS; Nightingale P; Situnayake RD; Thickett DR; Townend JN; Gordon C
Rheumatology (Oxford); 2009 Dec; 48(12):1506-11. PubMed ID: 19671698
[TBL] [Abstract][Full Text] [Related]
18. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.
Leuchte HH; Holzapfel M; Baumgartner RA; Ding I; Neurohr C; Vogeser M; Kolbe T; Schwaiblmair M; Behr J
J Am Coll Cardiol; 2004 Mar; 43(5):764-70. PubMed ID: 14998614
[TBL] [Abstract][Full Text] [Related]
20. Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older.
Ray P; Arthaud M; Birolleau S; Isnard R; Lefort Y; Boddaert J; Riou B
J Am Geriatr Soc; 2005 Apr; 53(4):643-8. PubMed ID: 15817011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
